Premium
The Efficacy and Safety of Furosemide and a Combination of Spironolactone and Hydrochlorothiazide in Congestive Heart Failure
Author(s) -
LEVY BENJAMIN
Publication year - 1977
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1977.tb04625.x
Subject(s) - spironolactone , furosemide , heart failure , hydrochlorothiazide , diuretic , aldosterone , thiazide , medicine , plasma renin activity , endocrinology , pharmacology , renin–angiotensin system , urology , cardiology , blood pressure
The therapeutic and biochemical effects of two commonly employed diuretic preparations were compared in a double-blind fashion in 32 patients with congestive heart failure. At the doses employed, furosemide and a fixed combination of spironolactone and hydrochlothiazide maintained control of the clinical manifestations of congestive heart failure to about the same degree. However, significant biochemical changes in the renin-aldosterone system were found in patients receiving the spironolactone/thiazide combination therapy. A significant increase in plasma renin activity and a significantly greater increase in aldosterone excretion were found in the spironolactone/thiazide group compared to the furosemide group. No significant differences were observed in serum potassium levels or 24-hour potassium excretion rates in patients treated with the two diuretic preparations.